1582-4934/asset/olbannerleft.gif?v=1&s=9ac4fbc1c8dd6b354380356601e09fc12424db35)
1582-4934/asset/olbannerright.gif?v=1&s=cd3126c456d5857b7dbedcf7ab88bbd934f98dcc)
You have open access to this content
Transforming growth factor-β1 elicits Nrf2-mediated antioxidant responses in aortic smooth muscle cells
Article first published online: 8 AUG 2009
DOI: 10.1111/j.1582-4934.2009.00874.x
© 2009 The Authors Journal compilation © 2009 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Total views since August 2010: 72
Additional Information
How to Cite
Churchman, A. T., Anwar, A. A., Li, F. Y.L., Sato, H., Ishii, T., Mann, G. E. and Siow, R. C.M. (2009), Transforming growth factor-β1 elicits Nrf2-mediated antioxidant responses in aortic smooth muscle cells. Journal of Cellular and Molecular Medicine, 13: 2282–2292. doi: 10.1111/j.1582-4934.2009.00874.x
Publication History
- Issue published online: 26 NOV 2009
- Article first published online: 8 AUG 2009
- Received: June 26, 2008; Accepted: November 25, 2008
- Abstract
- Article
- References
- Cited By
- Cumulative Usage
References
- 1, , , et al. Transforming growth factor-β mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol. 2002; 22: 975–82.
- 2. TGF-β and TGF-β receptors in atherosclerosis. Cytokine Growth Factor Rev. 2000; 11: 103–14.
- 3. Transforming growth factor-β and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc Biol. 2004; 24: 399–404.
- 4, , , et al. Overexpression of transforming growth factor-β1 stabilizes already-formed aortic aneurysms: a first approach to induction of functional healing by endovascular gene therapy. Circulation. 2005; 112: 1008–15.
- 5, , , et al. Increased expression of transforming growth factor-β1 as a stabilizing factor in human atherosclerotic plaques. Stroke. 2004; 35: 2253–7.
- 6, . The role of transforming growth factor-β in atherosclerosis: novel insights and future perspectives. Curr Opin Lipidol. 2002; 13: 523–9.
- 7, . Oxidative stress and cardiovascular injury – part I: basic mechanisms and in vivo monitoring of ROS. Circulation. 2003; 108: 1912–6.
- 8. Oxidative stress and coronary plaque stability. Arterioscler Thromb Vasc Biol. 2002; 22: 1751–2.
- 9, , . NAD(P)H oxidase – role in cardiovascular biology and disease. Circ Res. 2000; 86: 494–501.
- 10, , , et al. NAD(P)H oxidase 4 mediates transforming growth factor-β 1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res. 2005; 97: 900–7.
- 11, , , et al. Reactive oxygen species production via NADPH oxidase mediates TGF-β induced cytoskeletal alterations in endothelial cells. Am J Physiol. 2005; 289: F816–25.
- 12, , . Heme oxygenase carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide? Cardiovasc Res. 1999; 41: 385–94.
- 13. Heme oxygenase-1: a therapeutic amplification funnel. FASEB J. 2005; 19: 1216–9.
- 14. The heme oxygenase system: a regulator of second messenger gases. Ann Rev Pharmacol Toxicol. 1997; 37: 517–54.
- 15, , , et al. Biliverdin reductase: A major physiologic cytoprotectant. Proc Natl Acad Sci. 2002; 99: 16093–8.
- 16, , , et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nature Med. 2000; 6: 422–8.
- 17, , , et al. Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1. Br J Pharmacol. 1998; 125: 1437–44.
- 18, , , et al. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol. 1998; 152: 711–20.
- 19, , , et al. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2001; 104: 1519–25.
- 20, , , et al. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nature Med. 2003; 9: 183–90.
- 21, , , et al. Induction of heme oxygenase 1 by moderately oxidized low-density lipoproteins in human vascular smooth muscle cells: role of mitogen-activated protein kinases and Nrf2. Free Radic Biol Med. 2005; 39: 227–36.
- 22, , , et al. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages – activation by oxidatively modified LDL and 4-hydroxynonenal. Circ Res. 2004; 94: 609–16.
- 23, , . Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Ann Rev Pharmacol Toxicol. 2003; 43: 233–60.
- 24, , , et al. Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism. J Biol Chem. 2000; 275: 39907–13.
- 25, . Signal transduction by the TGF-β superfamily. Science. 2002; 296: 1646–7.
- 26, , , et al. SMAD and p38 MAPK signaling pathways independently regulate alpha 1(I) collagen gene expression in unstimulated and transforming growth factor-alpha-stimulated hepatic stellate cells. J Biol Chem. 2005; 280: 10055–64.
- 27, , , et al. TGF-β1 stimulates HO-1 via the p38 mitogen-activated protein kinase in A549 pulmonary epithelial cells. Am J Physiol. 2002; 283: L1094–102.
- 28, , , et al. p53 regulation by post-translational modification and nuclear retention in response to diverse stresses. Oncogene. 1999; 18: 7656–65.
- 29, . Reaction of reduced flavins and flavoproteins with diphenyliodonium chloride. J Biol Chem. 2002; 277: 41507–16.
- 30, , , et al. Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signalling. Nature. 1997; 389: 631–5.
- 31, , . Smad7 gene transfer attenuates adventitial cell migration and vascular remodeling after balloon injury. Arterioscler Thromb Vasc Biol. 2005; 25: 1383–7.
- 32, , , et al. Electron spin resonance characterization of the NAD(P)H oxidase in vascular smooth muscle cells. Free Radic Biol Med. 2001; 30: 603–12.
- 33, , , et al. Measurement of NAD(P)H oxidase-derived superoxide with the luminol analogue L-012. Free Radic Biol Med. 2004; 36: 101–11.
- 34, , , et al. The role of the methoxyphenol apocynin, a vascular NADPH oxidase inhibitor, as a chemopreventative agent in the potential treatment of cardiovascular diseases. Curr Vasc Pharmacol. 2008; 6: 204–17.
- 35, , , et al. Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J Biol Chem. 2002; 277: 44765–71.
- 36, , , et al. Transforming growth factor-β 1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am J Physiol. 2006; 290: L661–73.
- 37
- 38, , . Nrf2 defends the lung from oxidative stress. Antioxid Redox Signal. 2006; 8: 76–87.
- 39, , . Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxid Redox Signal. 2006; 8: 99–106.
- 40, . Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-β: implications for carcinogenesis. Oncogene. 2005; 24: 5742–50.
- 41, , , et al. Transforming growth factor-β1-induced expression of smooth muscle marker genes involves activation of PKN and p38 MAPK. J Biol Chem. 2005; 280: 31172–81.
- 42, , , et al. Role of reactive oxygen species in TGF-β1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol. 2005; 16: 667–75.
- 43, , , et al. Smad and p38-MAPK signaling mediates apoptotic effects of transforming growth factor-β1 in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2004; 287: L515–24.
- 44, , , et al. Heme oxygenase-1 contributes to the cytoprotection of alpha-lipoic acid via activation of p44/42 mitogen-activated protein kinase in vascular smooth muscle cells. Free Radic Biol Med. 2006; 40: 1313–22.
- 45, , , et al. Induction of heme oxygenase-1 is involved in anti-proliferative effects of paclitaxel on rat vascular smooth muscle cells. Biochem Biophys Res Commun. 2004; 321: 132–7.
- 46, , , et al. Functional association of nox1 with p22phox in vascular smooth muscle cells. Free Radic Biol Med. 2004; 37: 1542–9.
- 47, , , et al. c-Src and hydrogen peroxide mediate transforming growth factor-β1-induced smooth muscle cell-gene expression in 10T1/2 cells. Arterioscler Thromb Vasc Biol. 2005; 25: 341–7.
- 48, , , et al. NADPH oxidase mediates tissue factor-dependent surface procoagulant activity by thrombin in human vascular smooth muscle cells. Circulation. 2002; 105: 2030–6.
- 48, , , et al. Oxidative stress and expression of p22phox are involved in the up-regulation of tissue factor in vascular smooth muscle cells in response to activated platelets. FASEB J. 2000; 14: 1518–28.
- 50, , , et al. NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ Res. 2000; 86: 514–19.
- 51, , , et al. Redox imbalance in cystine/glutamate transporter-deficient mice. J Biol Chem. 2005; 280: 37423–9.
- 52, , , et al. Vitamin C inhibits diethylmaleate-induced L-cystine transport in human vascular smooth muscle cells. Free Radic Biol Med. 2003; 34: 103–10.
- 53, , , et al. Cystine uptake and glutathione level in endothelial cells exposed to oxidative stress. Am J Physiol. 1992; 262: C50–8.
- 54, , , et al. Hydrogen peroxide increases extracellular matrix mRNA through TGF-β in human mesangial cells. Kidney Int. 2001; 59: 87–95.
- 55, , , et al. Smad7-dependent regulation of heme oxygenase-1 by transforming growth factor-β in human renal epithelial cells. J Biol Chem. 2000; 275: 40904–9.
- 56, , . Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation. 1997; 96: 3602–9.
- 57, , et al . Mechanism of hydrogen peroxide-induced cell cycle arrest in vascular smooth muscle. Antioxid Redox Signal. 2002; 4: 845–4.
- 58, , . Smad7 sensitizes tumor necrosis factor induced apoptosis through the inhibition of antiapoptotic gene expression by suppressing activation of the nuclear factor-kappaB pathway. Cancer Res. 2007; 67: 9577–83.
- 59, , , et al. Smad7 inhibits the survival nuclear factor kappaB and potentiates apoptosis in epithelial cells. Oncogene. 2001; 20: 879–84.
- 60, , , et al. Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2/ARE complex to promote vascular smooth muscle cell survival. Cardiovasc Res. 2007; 75: 381–9.
- 61, , , et al. Protection of human vascular smooth muscle cells from H2O2-induced apoptosis through functional codependence between HO-1 and AKT. Arterioscler Thromb Vasc Biol. 2006; 26: 2027–34.
- 62, . p53 brings a new twist to the Smad signaling network. Sci Signal. 2008; 1: pe33.
- 63, , , et al. Different quantitative apoptotic traits in coronary atherosclerotic plaques from patients with stable angina pectoris and acute coronary syndromes. Circulation. 2004; 110: 1767–73.
- 64, , . p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J. 1999; 18: 6027–36.
- 65, , , et al. Smad3-ATF3 signaling mediates TGF-β suppression of genes encoding Phase II detoxifying proteins. Free Radic Biol Med. 2005; 38: 375–87.
- 66, , , et al. Nrf2, a multi-organ protector FASEB J. 2005; 19: 1061–6.